| ²é¿´: 12107 | »Ø¸´: 1 | ||
547starľ³æ (ÖøÃûдÊÖ)
|
[ÇóÖú]
CD16ÓëCD16/32ÓÐÊ²Ã´Çø±ð£¬²éCD16¿¹ÌåµÄʱºò¿´µ½ÕâÑù2ÖÖ ÒÑÓÐ1È˲ÎÓë
|
| CD16ÓëCD16/32ÓÐÊ²Ã´Çø±ð£¬²éCD16¿¹ÌåµÄʱºò¿´µ½ÕâÑù2ÖÖ£¬¼ì²â·¶Î§ºÍÕë¶ÔµÄÌØµãÓÐʲô²»Í¬£¿ |
» ²ÂÄãϲ»¶
Èç¹û´Ë¿ÌÄãÕýÔÚΪ¹ú»ù¸Ðµ½½¹ÂÇ£¬²»·ÁÀ´ÌýÌýÕâÊס¶»ù½ðÖ®Íâ¡·
ÒѾÓÐ6È˻ظ´
ÎÒÃæÉÏÍêµ°ÁË
ÒѾÓÐ10È˻ظ´
ÄÜ·ñÍ˳ö²ÎÓëµÄÃæÉÏÏîÄ¿½â³ýÏÞÏî
ÒѾÓÐ24È˻ظ´
filecode£¬4¸öjtjcÁË
ÒѾÓÐ17È˻ظ´
ÈËÆø²»ÐÐÁË
ÒѾÓÐ9È˻ظ´
ûÓÐÈκÎÏûÏ¢-ÊDz»ÊǾÍÁ¹ÁË
ÒѾÓÐ6È˻ظ´
2026¹ú×ÔÈ»º¯ÆÀ·Ñµ½ÕË
ÒѾÓÐ19È˻ظ´
½¨Òé»ù½ð·¢²¼Ìáǰ¸ø³öÃ÷È·µÄʱ¼äµã
ÒѾÓÐ16È˻ظ´
½ñÈÕ²»·Å°ñ£¿Íø´«¹ú×ÔȻԤ¼Æ 8 Ô 27 Èտɲé½á¹û
ÒѾÓÐ21È˻ظ´
¹À¼ÆÊÇÖÜËÄ
ÒѾÓÐ4È˻ظ´

tsyxy
¾èÖú¹ó±ö (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 3760.5
- Ìû×Ó: 174
- ÔÚÏß: 79.2Сʱ
- ³æºÅ: 1003555
- ×¢²á: 2010-04-22
- רҵ: Éñ¾ÏµÍ³ºÍ¾«Éñ¼²²¡
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
| CD16 is a 50-65 kDa cell surface molecule that exists in two forms - a transmembranous form expressed by natural killer (NK) cells, and some T cells and a phosphatidylinositol linked form expressed by granulocytes. CD16 is a low affinity receptor for IgG (FcR III), and is an important receptor mediating ADCC (antibody dependent cell mediated cytotoxicity) by NK cells. IN comparison, CD32 is a 40 kD glycoprotein that acts as a low affinity receptor for IgG (also known as Fc gamma RII), and mediates several functions including endocytosis, activation of secretion, cytotoxicity and immunomodulation. CD32 is expressed by B cells, monocytes, granulocytes and platelets. Further, CD32 is involved in the phagocytosis of immune complexes, the regulation of antibody production by B-cells, and variations of the CD32 gene may increase vulnerability to systemic lupus erythematosus (SLE). Several transcript variants encoding different isoforms of CD32 have been found. |
2Â¥2019-12-15 09:03:04









»Ø¸´´ËÂ¥
20